Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy

The FDA granted CYB003 — an investigational depression treatment that acts as a deuterated psilocybin analog — a breakthrough therapy designation after patients achieved an

Fra­zier Life Sci­ences, a decades-old biotech in­vestor, is rais­ing an­oth­er heap of dry pow­der to cre­ate and in­vest in star­tups, ac­cord­ing to pub­licly avail­able doc­u­ments